External Quality Assessment 2.0: The Importance of a Standardized Implementation of TILs for Daily and Trial Practices.

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
02 Aug 2022
Historique:
received: 19 07 2022
accepted: 28 07 2022
entrez: 12 8 2022
pubmed: 13 8 2022
medline: 13 8 2022
Statut: epublish

Résumé

Increasing data suggests that an intact immune system is required for improvedoutcomes in patients with Human Epidermal Growth Factor Receptor 2 (HER2+) and Triple Negative Breast Cancer (TNBC) [...].

Identifiants

DOI: 10.3390/cancers14153762 PMID: 35954426 PMC: PMC9367276
pubmed: 35954426
pii: cancers14153762
doi: 10.3390/cancers14153762
pmc: PMC9367276
pii:
doi:

Types de publication

Editorial

Langues

eng

Références

Ann Oncol. 2015 Feb;26(2):259-71
pubmed: 25214542
Clin Chem Lab Med. 2016 Apr;54(4):545-51
pubmed: 26744251
NPJ Breast Cancer. 2020 May 12;6:16
pubmed: 32411818
Arch Pathol Lab Med. 2021 Sep 1;145(9):1132-1137
pubmed: 33417715
Cancer J. 2021 Jan-Feb 01;27(1):25-31
pubmed: 33475290
Lancet Oncol. 2020 Nov;21(11):1399-1401
pubmed: 33098760
J Natl Cancer Inst. 2021 Aug 2;113(8):1005-1016
pubmed: 33523233
J Pathol. 2020 Apr;250(5):667-684
pubmed: 32129476
Mod Pathol. 2016 Oct;29(10):1155-64
pubmed: 27363491
Br J Cancer. 2018 Aug;119(5):605-614
pubmed: 30140047
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Ann Clin Lab Sci. 2017 Nov;47(6):649-656
pubmed: 29263037

Auteurs

Inne Nauwelaers (I)

Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, University of Leuven, Kapucijnenvoer 35d, 3000 Leuven, Belgium.
ORCID: 0000-0003-3577-6776

Nele Laudus (N)

Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, University of Leuven, Kapucijnenvoer 35d, 3000 Leuven, Belgium.
ORCID: 0000-0001-6876-3475

Dieter Peeters (D)

CellCarta NV, 2610 Antwerp, Belgium.
Department of Pathology, AZ Sint-Maarten, 2800 Mechelen, Belgium.

Balazs Acs (B)

Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institute, 171 64 Stockholm, Sweden.
Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
ORCID: 0000-0002-0972-4633

Carsten Denkert (C)

Institute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM), Baldingerstr. 1, 35043 Marburg, Germany.

Stefan Michiels (S)

Department of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, 94800 Villejuif, France.
Oncostat U1018, Inserm, Labeled Ligue Contre le Cancer, University Paris-Saclay, 94800 Villejuif, France.

Hugo Horlings (H)

Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

Kalliopi P Siziopikou (KP)

Department of Pathology, Section of Breast Pathology, Northwestern University, Chicago, IL 60611, USA.

Scott Ely (S)

Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08540, USA.

Dimitrios Zardavas (D)

Oncology Clinical Development, Bristol-Myers Squibb, Princeton, NJ 08540, USA.

Roberts Mustimbo (R)

Translational Medicine, Bristol-Myers Squibb, Princeton, NJ 08540, USA.

John Bartlett (J)

Edinburgh Cancer Research Centre, Institute of Genetics and Molecular Medicine, Edinburgh EH4 2XR, UK.

Giuseppe Floris (G)

Laboratory of Translational Cell & Tissue Research, Department of Imaging and Pathology, University of Leuven, 3000 Leuven, Belgium.
Department of Pathology, University Hospitals Leuven, 3000 Leuven, Belgium.

Johan Hartman (J)

Department of Oncology and Pathology, Cancer Center Karolinska, Karolinska Institute, 171 64 Stockholm, Sweden.
Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, 171 76 Stockholm, Sweden.
ORCID: 0000-0002-6500-8527

Carolien H M van Deurzen (CHM)

Department of Pathology, Erasmus Medical Center-Cancer Institute, 3015 GD Rotterdam, The Netherlands.

Dorien Ceusters (D)

Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, University of Leuven, Kapucijnenvoer 35d, 3000 Leuven, Belgium.
ORCID: 0000-0002-2436-0284

Els Dequeker (E)

Biomedical Quality Assurance Research Unit, Department of Public Health and Primary Care, University of Leuven, Kapucijnenvoer 35d, 3000 Leuven, Belgium.
ORCID: 0000-0001-5383-3178

Roberto Salgado (R)

Department of Pathology, GZA-ZNA Hospitals, 2610 Antwerp, Belgium.
Division of Research, Peter Mac Callum Cancer Centre, Melbourne, VIC 300, Australia.

Classifications MeSH